Thymosin Alpha-1

A 28-amino-acid peptide derived from thymosin fraction 5. Used clinically in some countries (not FDA-approved in the US) for chronic hepatitis B and as an immune modulator.

What does Thymosin Alpha-1 mean in peptide research?

A 28-amino-acid peptide derived from thymosin fraction 5. Used clinically in some countries (not FDA-approved in the US) for chronic hepatitis B and as an immune modulator. This term is part of the broader field of peptide research, which encompasses both FDA-approved therapeutic peptides and research-grade compounds used in scientific investigation.

Why this term matters

Understanding Thymosin Alpha-1 is foundational for anyone reviewing peptide research literature, comparing different research compounds, or following regulatory developments in this field. The term appears across pharmacology textbooks, FDA documentation, and clinical trial reports.

Where to learn more

For deeper context, see our peptide research articles:

• What Are Peptides? Comprehensive Introduction
• Research-grade vs Clinical-grade Peptides
• FDA Peptide Regulatory Status 2026
• Full Peptide Glossary Article